SS Innovations responds to FDA 510(k) request
- Submitted response to FDA on Oct 5, 2026
- Completed human clinical study for SSi Mantra
- FDA review expected in Q1 2027
Every EDGAR filing for SS Innovations International, Inc. (SSII), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 13 · 10-Q expected ~Nov 13 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Srivastava Sudhir, reporting
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Sarah Romano, new insider at SSII
Sarah Romano, reporting
Pascual Srivastava Vishwajyoti, insider filing for SSII
Pascual Srivastava Vishwajyoti, reporting
Barry F Cohen, insider filing for SSII
Barry F Cohen, reporting
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Ownership stake disclosure by Srivastava Sudhir (amended)
Srivastava Sudhir, filed by
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Barry F Cohen, insider filing for SSII
Barry F Cohen, reporting
Barry F Cohen, insider filing for SSII
Barry F Cohen, reporting
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Srivastava Sudhir, insider filing for SSII
Srivastava Sudhir, reporting
Frederic H Moll, insider filing for SSII
Frederic H Moll, reporting